Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Neoplastic Stem Cells in Cutaneous Lymphomas

Neoplastic Stem Cells in Cutaneous Lymphomas COMMENTARY Evidence and Clinical Implications HE DEVELOPMENT OF vided important clues to the under- eage (B and T cells, natural killer many cancers and he- standing of the pathogenesis of can- cells, a subpopulation of dendritic matologic neoplasms cer. Leukemias (and in certain cases cells) (Figure 1). is driven by neoplas- solid tumors) seem to represent mul- Recent evidence suggests that T tic stem cells. These ticellular systems founded by a trans- many hematologic neoplasms and cells constitute a small proportion formed stem cell that undergoes ab- solid cancers contain a small frac- of the tumor mass and have low mi- errant differentiation into the final tion of stem cells that are capable of 4-6 totic activity but demonstrate abil- phenotype (Figure 1). indefinite proliferation and drive the 5,6 ity of efficient self-renewal. In this review I explore the growth of tumors. These neoplas- available evidence that suggests a tic stem cells (which in the case of See also page 1057 similar scenario for cutaneous lym- lymphoma will be called lymphoma phomas. I will in particular deal with stem cells [LSCs]) resemble func- It has long been recognized that the possibility that certain lympho- tionally normal hematopoietic stem many http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Dermatology American Medical Association

Neoplastic Stem Cells in Cutaneous Lymphomas

JAMA Dermatology , Volume 140 (9) – Sep 1, 2004

Loading next page...
 
/lp/american-medical-association/neoplastic-stem-cells-in-cutaneous-lymphomas-b66smK749D

References (35)

Publisher
American Medical Association
Copyright
Copyright 2004 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6068
eISSN
2168-6084
DOI
10.1001/archderm.140.9.1156
pmid
15381560
Publisher site
See Article on Publisher Site

Abstract

COMMENTARY Evidence and Clinical Implications HE DEVELOPMENT OF vided important clues to the under- eage (B and T cells, natural killer many cancers and he- standing of the pathogenesis of can- cells, a subpopulation of dendritic matologic neoplasms cer. Leukemias (and in certain cases cells) (Figure 1). is driven by neoplas- solid tumors) seem to represent mul- Recent evidence suggests that T tic stem cells. These ticellular systems founded by a trans- many hematologic neoplasms and cells constitute a small proportion formed stem cell that undergoes ab- solid cancers contain a small frac- of the tumor mass and have low mi- errant differentiation into the final tion of stem cells that are capable of 4-6 totic activity but demonstrate abil- phenotype (Figure 1). indefinite proliferation and drive the 5,6 ity of efficient self-renewal. In this review I explore the growth of tumors. These neoplas- available evidence that suggests a tic stem cells (which in the case of See also page 1057 similar scenario for cutaneous lym- lymphoma will be called lymphoma phomas. I will in particular deal with stem cells [LSCs]) resemble func- It has long been recognized that the possibility that certain lympho- tionally normal hematopoietic stem many

Journal

JAMA DermatologyAmerican Medical Association

Published: Sep 1, 2004

There are no references for this article.